These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 22061183

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Understanding and interpreting vision safety issues with vigabatrin therapy.
    Plant GT, Sergott RC.
    Acta Neurol Scand Suppl; 2011; (192):57-71. PubMed ID: 22061181
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Which children receive vigabatrin? Characteristics of pediatric patients enrolled in the mandatory FDA registry.
    Pellock JM, Faught E, Foroozan R, Sergott RC, Shields WD, Ziemann A, Lee D, Dribinsky Y, Torri S, Othman F, Isojarvi J.
    Epilepsy Behav; 2016 Jul; 60():174-180. PubMed ID: 27208827
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
    Schwarz MD, Li M, Tsao J, Zhou R, Wu YW, Sankar R, Wu JY, Hussain SA.
    Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Visual field constriction on vigabatrin.
    Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Visual fields at school-age in children treated with vigabatrin in infancy.
    Gaily E, Jonsson H, Lappi M.
    Epilepsia; 2009 Feb; 50(2):206-16. PubMed ID: 19215279
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study.
    Riikonen R, Rener-Primec Z, Carmant L, Dorofeeva M, Hollody K, Szabo I, Krajnc BS, Wohlrab G, Sorri I.
    Dev Med Child Neurol; 2015 Jan; 57(1):60-7. PubMed ID: 25145415
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vigabatrin therapy for refractory complex partial seizures: review of major European trials.
    Ben-Menachem E, Sander JW.
    Acta Neurol Scand Suppl; 2011 Jan; (192):16-28. PubMed ID: 22061177
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review.
    Maguire MJ, Hemming K, Wild JM, Hutton JL, Marson AG.
    Epilepsia; 2010 Dec; 51(12):2423-31. PubMed ID: 21070215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.